Autopsy report · NCT01105325

Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care

“due to poor patient recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 11 months before it stopped.
• 1,000 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

AstraZeneca

Sponsor type

Industry

Conditions

Acute Coronary Syndrome

Participants

1,000 (planned, not actual)

Sites

49

Countries

France

Trials that died the same way

• The Risk of Intraventricular Hemorrhage With Flat Midline Versus Right-Tilted Flat Lateral Head Positions
  “Due to low patient recruitment” (96% match in meaning)
• The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery
  “Poor patient recruitment” (93% match in meaning)
• Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)
  “Poor recruitment, poor patient compliance, lack of funding” (88% match in meaning)
• Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
  “Due to poor patient recruitment and insufficient financing.” (87% match in meaning)
• Fesoterodine on Urgency Episodes in Parkinson's Disease Population
  “Insufficient or untimely patient recruitment” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.